
Cronos Group CRON
€ 2.29
-0.93%
Quartalsbericht 2026-Q1
hinzugefügt 11.05.2026
Cronos Group Finanzkreislauf 2011-2026 | CRON
Finanzkreislauf Jährlich Cronos Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.7 | 45.7 | 77.6 | 48.6 | - | 213 | 278 | 605 | 592 | 1.52 K | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.52 K | 45.7 | 383 |
Finanzkreislauf anderer Aktien in der Arzneimittelhersteller
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Endo International plc
ENDP
|
141 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
55.1 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
-227 | $ 5.59 | -0.27 % | $ 83 M | ||
|
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
-38 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
-4.1 K | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-224 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
460 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
-206 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
-128 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
137 | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
-46.2 | $ 39.34 | 4.5 % | $ 1.45 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
192 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
110 | - | - | $ 11.5 B | ||
|
Organogenesis Holdings
ORGO
|
106 | $ 2.38 | 1.71 % | $ 302 M | ||
|
Eagle Pharmaceuticals
EGRX
|
139 | - | -39.89 % | $ 27.7 M | ||
|
Pacira BioSciences
PCRX
|
209 | $ 22.84 | -0.65 % | $ 1.06 B | ||
|
Canopy Growth Corporation
CGC
|
177 | $ 1.02 | 2.01 % | $ 110 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
150 | $ 1.15 | 5.4 % | $ 1.43 M | ||
|
Aurora Cannabis
ACB
|
1.45 K | $ 3.17 | 4.11 % | $ 174 M | ||
|
Jupiter Wellness
JUPW
|
-186 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
173 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
2.92 K | $ 1.06 | -0.47 % | $ 101 M | ||
|
Tilray
TLRY
|
169 | $ 5.11 | 2.51 % | $ 3.16 B | ||
|
Evolus
EOLS
|
74.8 | $ 6.66 | -1.04 % | $ 429 M | ||
|
Emergent BioSolutions
EBS
|
360 | $ 8.35 | 0.36 % | $ 447 M | ||
|
cbdMD
YCBD
|
83 | $ 0.7 | 2.06 % | $ 2.82 M | ||
|
Veru
VERU
|
19.6 | $ 3.13 | 4.33 % | $ 45.8 M | ||
|
Assertio Holdings
ASRT
|
467 | $ 23.49 | 0.04 % | $ 150 M | ||
|
ProPhase Labs
PRPH
|
136 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
-35 | - | - | $ 1.42 B | ||
|
Bausch Health Companies
BHC
|
79.8 | $ 5.08 | 0.4 % | $ 1.88 B | ||
|
PetIQ
PETQ
|
53.8 | - | 1.64 % | $ 400 M | ||
|
Recro Pharma
REPH
|
105 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
491 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
2.74 | $ 4.31 | 1.89 % | $ 215 M | ||
|
PLx Pharma
PLXP
|
113 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
150 | $ 16.42 | -0.39 % | $ 19.2 B | ||
|
Zomedica Corp.
ZOM
|
154 | - | -0.21 % | $ 98 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
14.6 K | - | - | $ 55.5 M | ||
|
Rockwell Medical
RMTI
|
57 | $ 0.65 | 3.92 % | $ 23.4 M | ||
|
China Pharma Holdings
CPHI
|
139 | $ 0.74 | -0.15 % | $ 3.18 M | ||
|
TherapeuticsMD
TXMD
|
-723 | $ 2.29 | 4.09 % | $ 26.5 M |